Intignus Biotech
PrivateLast Round
Grant
Nov 1, 2025
Total Funding Raised
$1.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Intignus Biotech is a biotechnology company that develops diagnostic devices and point-of-care tests for the early detection of pregnancy-related disorders and maternal health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intignus Biotech Comparables
Compare Intignus Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prantae Solutions | 82% | |
| MOMM Diagnostics | 81% | |
| Kalia Health, Inc. | 77% |
Intignus Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2025 | ||||
| Accelerator | Mar 15, 2023 | ||||
| VC Round | Dec 20, 2022 | ||||
| Grant | Aug 20, 2020 |
Intignus Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant, VC Round |
| Villgro | Grant |
| Department of Science & Technology | Grant |
| Gates Foundation | Grant |
| Tech4Eva | Accelerator |
| Venture Center | VC Round |
| EPFL Innovation Park | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 274% MoM.
- Nov 1, 2025
$900K grant from the Gates Foundation.
Intignus Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Intignus Biotech's valuation, stock price, and market status.
Is Intignus Biotech a public or private company?
Intignus Biotech is a private company.
What is the current stock price of Intignus Biotech?
Intignus Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Intignus Biotech worth (valuation)?
Valuation information for Intignus Biotech is not publicly available.
Can I buy Intignus Biotech stock?
Intignus Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Intignus Biotech's last funding round?
Intignus Biotech's most recent funding round was Grant on November 1, 2025.
Who are the main investors in Intignus Biotech?
Key investors in Intignus Biotech include Biotechnology Industry Research Assistance Council, Gates Foundation, Tech4Eva.
Will Intignus Biotech IPO soon?
No public IPO plans have been announced for Intignus Biotech.
How can I track Intignus Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Intignus Biotech's secondary market activity and sign up for updates.